Pakistan
Industry
GlaxoSmithKline Pakistan's financial performance has been impaired by a challenging business environment, according to the company's senior executive. In an interview with Bloomberg,...
2010-07-09Industry
BMI believes the strategy adopted by Searle Pakistan is advisable given the challenging operating environment in the South Asian country. The Karachi-based drugmaker dramatically...
2010-04-21Industry
Combined sales of prescription drugs and over-the-counter (OTC) medicines in Pakistan are forecast to increase from PKR132bn (US$1.62bn) in 2009 to PKR144bn (US$1.64bn) in 2010. Due...
2010-04-20Industry
Pakistan's US$1.62bn pharmaceutical market is the 10th largest in Asia Pacific, behind the Philippines (US$2.58bn) and ahead of Vietnam (US$1.53bn). Annual per-capita spending on medicines...
2010-04-19Industry
Healthcare spending in Pakistan is expected to increase from PKR227bn (US$2.76bn) in 2009 to PKR257bn (US$2.86bn) in 2010. Due to depreciation of the rupee, this equates to growth...
2010-01-18Industry
The pharmaceutical pricing regime in Pakistan is typical of an emerging market and far below international standards. Both generic drugs and patented products are subject to price...
2010-01-05Industry
The Aga Khan Agency for Microfinance (AKAM) has established a healthcare insurance service in Pakistan. The First Microinsurance Agency (FMiA) will offer three products in conjunction...
2009-11-12Industry
Pakistan's ambition to become a significant exporter of pharmaceuticals is under threat. A Ugandan drugmaker has sued a pharmaceutical manufacturer from the South Asian country for...
2009-09-08
